chloroquine and 2,3-bis(bromomethyl)quinoxaline-1,4-dioxide

chloroquine has been researched along with 2,3-bis(bromomethyl)quinoxaline-1,4-dioxide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brizuela, M; Burgio, G; Foote, SJ; Huang, HM; McMorran, BJ; Smith, C	1

Other Studies

1 other study(ies) available for chloroquine and 2,3-bis(bromomethyl)quinoxaline-1,4-dioxide

Article	Year
Treatment of erythrocytes with the 2-cys peroxiredoxin inhibitor, Conoidin A, prevents the growth of Plasmodium falciparum and enhances parasite sensitivity to chloroquine. PloS one, 2014, Volume: 9, Issue:4 Topics: Animals; Antimalarials; Apoptosis; Cells, Cultured; Chloroquine; Cysteine; Erythrocytes; Homeodomain Proteins; Humans; Immunoblotting; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinoxalines	2014

Article

Year

Treatment of erythrocytes with the 2-cys peroxiredoxin inhibitor, Conoidin A, prevents the growth of Plasmodium falciparum and enhances parasite sensitivity to chloroquine.

PloS one, 2014, Volume: 9, Issue:4

Topics: Animals; Antimalarials; Apoptosis; Cells, Cultured; Chloroquine; Cysteine; Erythrocytes; Homeodomain Proteins; Humans; Immunoblotting; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinoxalines

2014